Filing Flows › Smith & Nephew (SNN) › Recalls, complaints & regulation
Smith & Nephew (SNN): recalls and clinical trials
Smith & Nephew (SNN) beyond its filings: 2 recalls in the last 12 months (37 in five years, 0 Class I); 25 active clinical trials.
Latest recalls
- 2026-06-24 · FDA device · TRIGEN PROXIMAL STRAIGHT HUMERAL NAIL 8/7 X 16, REF: 71760816
- 2025-12-24 · FDA device · BIOSURE HA SCREW, 6MM x 20 MM. Threaded metallic bone fixation fastener.
- 2025-05-28 · FDA device · META-TAN LAG/COMPRESSION SCREW KIT 90MM/85MM, REF: 71642690
- 2024-12-11 · FDA device · BIORAPTOR Suture Anchors. Tendon/ligament, non-bioabsorbable bone anchor.
- 2024-12-04 · FDA device · RENASYS EDGE The RENASYS¿ EDGE pump is indicated for patients who would benefit from a suction pump (NPWT), as it may promote wound healing via removal of fl
- 2024-11-13 · FDA device · Tandem Intl Bipolar Cocr Shell/UHMWPE Liner, TI-6AL-4V Retaining Ring, 28MM I.D. 46 MM O.D., REF 71324046, sterile, femoral head bipolar component of the Tandem
- 2024-11-06 · FDA device · smith&nephew LEIGON OXINIUM CONSTRAINED NONPOROUS FEMORAL COMPONENT, SIZE 4 LEFT, REF 71421164; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTE
- 2024-11-06 · FDA device · smith&nephew LEGION OXINIUM POSTERIOR STABILIZED NONPOROUS FEMORAL COMPONENT, SIZE 5N, RIGHT, NARROW, REF 71421275; Uncoated knee femur prosthesis, metallic
Smith & Nephew's latest quarter
Smith & Nephew, H1 2026: revenue $3.1B (+5% year over year), operating margin 14.5%, net earnings $303M, operating cash flow $450M. The chart follows the revenue to costs, profit and cash.
Questions
Has Smith & Nephew had any recalls?
37 recalls on file over five years from the FDA, CPSC and NHTSA; 2 in the last 12 months.
How many clinical trials does Smith & Nephew have?
25 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.